Abstract
Subjects and methods
Mathematical model Conclusion. Even with present rates the prevalence of haemodialysis patients in Denmark will continue to We used a Markov model [10 ] to describe the influx and efflux of patients from the following states [7-9]: (1 ) alive increase. Mathematical models offers a good tool to and not on RRT (i.e. the background population); ( 2) on study future trends and to plan future capacity.
Where Ns is the prevalence (stock) of patients at 31 December in the year y (e.g. 1992); N is the number of patients entering therapy for the first time (into H, rH; P, rP; T, rT ), changing between modalities (H to P, rHP etc.) or dying (e.g. patients on H dying, rHD) in the year between y and y+1. Example: if one thousand patients are on H at 31 December 1995, the rate of new patients is 100 p.m.p./year. in a population of 2 million inhabitants, the death rate is 10%, the number of patients living with a functioning renal graft is 1200, 5% lose their grafts and change to H each year, 30 H patients receive a renal graft per year and 15% of H patients change to P and 30% of P patients (500) change to H, the expected prevalence at 31 December 1996 is: 1000+100 p.m.p./year. * 2 million-0.1 * 1000+0.05 * 1200+0.3 * 500-0.15 * 1000-30=1120 patients.
The total prevalence of RRT patients is the sum of the prevalences for each treatment modality (H, P, and T ).
Upon stratifying into age groups a number of patients transferring from one age group to the next must also be included. In our model we divided the population into two age groups and assumed that a constant fraction of patients <60 years not dying or transferring to other therapy modalities would add to the age group Á60 years. It was also assumed that the number of patients transferring to or from other countries was negligible.
The development in the background population was estimated on the basis of the birth and death rates in 1993, a net immigration of 11 000 per year, and the age stratified preval- If the numbers and rates entered into the above specified dialysis; D, dead; and T, alive with functioning renal graft. r, rate model are predetermined (e.g. based on an assumption of ( probability) of transition from one state to another. In the analysis constant incidence rates) the model can be called determinthis model was stratified into two age groups, <60 and Á60 years istic. It is, however, well known that incidence rates and with an additional migration between the two age groups.
transition rates tends to vary from one year to another in a random (stochastic ) way. In the following calculations we will use the term deterministic to describe a model in which the incidence and transition rates have been predetermined, prevalence proportion is the number of patients on therapy and the term stochastic will describe a model in which the p.m.p. (e.g. 100 patients p.m.p.).
rates are brought to vary in a random way by simulation. We assumed that the annual transitions from one state to
We therefore assumed that the rates were approximately another could be described as a fraction of the prevalence in Gaussian distributed and that they varied randomly from that state at 31 December in the previous year. For example one year to the next. To simulate this random variation, we the transition rate ( probability of transferring) from haemogenerated a sample of pseudorandom numbers between 0 dialysis to peritoneal dialysis could be described as: rHP= and 1 [ 12] . Each number was assumed to correspond to the tHP/Hp where tHP is the number of patients transferring cumulated normal probability and thus with the transition from H to P and Hp is the haemodialysis prevalence (e.g. probability in that year. For example, if the pseudorandom 100 of 1000 H patients changes to P in 1 year, yielding a number was 0.5 it corresponded to the mean value. In the rate of 10%). From a practical point of view it is, however, case of H to P transitions among patients <60 years this unlikely that the number of renal graftings can be expressed meant a transition rate of 0.127 in that year. A figure of as a fraction of e.g. the number of H patients, so we chose 0.975 would mean a rate of 0.127+1.96 * 0.036=0.198, i.e. to express the number of graftings as an absolute number equivalent to the 97.5% percentile in the Gaussian distribuper year (e.g. if the prevalence of H patients increases from tion-cf. Table 1 . If the simulated transition rate was negative 1000 to 2000 it is unlikely that the number of graftings will it was substituted by the value zero. Should the simulated increase in consequence) [11] .
number of patients leaving P, for example, be greater than Thus the prevalence of RRT patients on any treatment the actual prevalence, the prevalence was assumed to be zero modality can be estimated by the following:
in the next year. Generated rates were compared with the
observed rates. The annual increase in incidence rates was studied by linear regression using the method of least squares.
Calculations were performed by Microsoft Excel 5.0 for Windows.
P: NsP(y+1)=NsT(y)+NrP(y)-NrPD(y)+NrTP(y)
Trends in time were analysed by log-rank test for trend or +NrHP(y)-NrPH(y)-NrPT(y) x2 test for trend and factors of significance to survival by Cox analysis (stepwise forward method with likelihood ratio).
T: NsT(y+1)=NsT(y)+NrT(y)-NrTD(y)+NrHT(y)
Kruskal-Wallis test and Mann-Whitney test were used to compare groups. +NrPT(y)-NrTP(y)-NrTH(y)
Results
(P=0.52) or year of treatment start (0.10) did not influence survival. Table 1 shows the transition rates. Variations are noted Figure 3 shows an example of a deterministic profrom one year to the next and from one treatment gnosis using the rates and numbers from Table 1 . The modality to another. The standard deviations demon-overall prevalence proportion would increase from 539 strates variability in the rates. As shown in Figure 2 p.m.p. in 1995 to about 777 p.m.p. in 2006. the overall incidence rates increased in the study period, Figure 4 shows a prognosis based on the average of and in the same period the death rates increased from 20 simulations using the stochastic model. 0.02 to 0.05 in patients <60 years and from 0.10 to
Comparison of the rates and numbers generated in 0.30 in patients Á60 years. The mean age of patients the stochastic model ( Figure 4 ) and the deterministic alive at 31 December increased significantly during the model (Figure 3 ) showed no significant differences. period from 48.5±15.2 years on 31 December 1990 to Interpreted together Figures 3 and 4 shows that the 50.7±16.0 years on 31 December 1995 ( 2p<0.001). prevalence of especially H in patients Á60 years and The mean age at 31 December 1995 of patients alive T in patients <60 years will increase. with a functioning renal graft was 44.7±14.2 years Figure 5 shows a prognosis using a linear increase (n=1184), for patients on H the mean age was in incidence rates in patients both <60 and Á60 years. 55.5±16.0 years (n=970), and for patients in P it was In this case the increase in the total number of RRT 55.5±15.2 years (n=454). The fraction of patients patients is even higher than in the earlier examples. In with diabetes also increased significantly (from 9 A superimposed linear trend is also shown for the incidence rates to underline the increasing rates: for patients <60 years, rate ( yr)=54+2.6 * ( yr -1991) p.m.p./yr, r2=0.67 and for patients Á60 years: rate( yr)=131+24 * ( yr -1991) p.m.p./yr, r2=0.71. Where yr is the actual year (e.g. 1992).
Fig. 3.
Markov model using a deterministic approach (see text) based on transition rates from Table 2 . The ordinate shows point prevalence at 31 December in each of the years (number of patients on actual treatment modality in Denmark). H, haemodialysis; P, peritoneal dialysis; and T, renal transplant recipient. Data from the years 1991 to 1995 are antecedent data. Total is the total prevalence; <60 and >60 represent patients under 60 years of age and those 60 or over. Fig. 4 . Expected number of patients using the average of 20 simulations based on a stochastic model that simulates the random variations in rates (see text). The ordinate shows the expected number of patients on the actual treatment modality (expressed as mean and one standard error of the mean). H, haemodialysis; P, peritoneal dialysis; and T, renal transplant recipients.
Discussion
The incidence rates [3,6 ] and transition rates [3,9,13] in our study are comparable with those found in other studies. It should, however, be observed that the transition rates are not comparable with technique survival calculated by Kaplan-Meier method [14] [15] [16] [17] . The age distribution [3,4] and fraction of diabetics [4 ] also resembles that seen in other countries.
The implementation of random variation demonstrates the uncertainties linked to the predictionsvariations which are difficult to assess in the deterministic model which uses predetermined rates specified by the user [7-9] (cf. Table 1 ) .
In the stochastic model the random variation in incidence and transition rates can be simulated and by repeating the simulation a number of times it is easy to study the variations originating from changes in rates and thus achieve a more adequate picture of possible future trends in the prevalence of patients. In our study we found that on average the two models generate equal predictions of prevalence, the stochastic model did, however, have an advantage in the calculation of confidence limits. Especially in smaller centres, where the number of observations are small and the rates variable, this type of modelling can be useful [8 ] .
In our simulation we performed calculations using fractions (e.g. 0.23 patients per year) but it is also possible to modify the calculations so that the generated numbers are rounded to the nearest integer.
In this paper we have generated the prognosis over a long time-span to illustrate the similarities between the two kinds of models. It should be remembered, however, that rates may change not only in a random way over time; systematic changes [13, 18] could also occur, e.g. increasing influx of patients Á60 years in H. This would change the picture as outlined in Figure 5 . In this case the number of patients Á60 years increases in a steeper way because only the incidence and not the mortality was assumed to increase. It would of course also be possible to study a situation in which the mortality rates were increasing. In our model both incidence and mortality rates seemed to increase; however, this only affected the long-term results. Instead of using a linear increase it would also be possible to use other models, e.g. an exponential increase in incidence rates. The prevalence of patients is thus a complicated result of many factors acting together and the increase (or decrease) may be subject to alterations especially in the long run due to changes in incidence and death rates with time. Over a short period, the uncertainties are limited. In a clinical situation it is thus possible to generate a fairly accurate estimate using rates from the latest years.
The increase in the prevalence of transplant recipients stems from their low mortality and not from increasing grafting activity. The low mortality is due to age and the fact that patients selected for grafting probably are more healthy than patients not offered grafting. The increase in the number of haemodialysis Table 1 . Rates of transition in the Markov model. The annual number of renal transplant recipients has been assumed to be constant. r, rate (probability) of transition; H, haemodialysis; P, peritoneal dialysis; T, renal transplantation; D, dead (e.g. rHP, transition rate from H to P; and rH, patients entering H for the first time). Numbers express the actual number of renal graftings, and /yr expresses the fraction migrating from one to another treatment modality, e.g. on average after 1 year 12.7% of the patients patients Á60 years is mainly due to the high influx In conclusion it seems important to describe expected future development in the number of RRT patients from the general population, from patients <60 years entering the next age group and from patients losing and to develop strategies to insure the most costeffective and patient-acceptable flux between the their grafts or transferring from P to H because for example of peritonitis (technique failure). Even a signi-different RRT modalities. ficant reduction of transition rates from P to H only seemed to modify the prevalence somewhat.
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